6634.TWO
Price:
$54.1
Market Cap:
$3.86B
Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company's products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicity-free analgesic medicines in the United States. The company was founded in 2014 and is based in Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2017-06-30
Stock Exchange
TWO
Ticker
6634.TWO
According to Sinew Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -24.15. This represents a change of -99.80% compared to the average of -12205.97 of the last 4 quarters.
The mean historical PE Ratio of Sinew Pharma Inc. over the last ten years is -37.42. The current -24.15 PE Ratio has changed 6.35% with respect to the historical average. Over the past ten years (40 quarters), 6634.TWO's PE Ratio was at its highest in in the June 2019 quarter at -6.02. The PE Ratio was at its lowest in in the December 2022 quarter at -46807.36.
Average
-37.42
Median
-40.03
Minimum
-56.02
Maximum
-12.64
Discovering the peaks and valleys of Sinew Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 343.04%
Maximum Annual PE Ratio = -12.64
Minimum Annual Increase = -46.50%
Minimum Annual PE Ratio = -56.02
Year | PE Ratio | Change |
---|---|---|
2024 | -22.55 | -19.17% |
2023 | -27.90 | -46.50% |
2022 | -52.15 | -2.11% |
2021 | -53.28 | -4.90% |
2020 | -56.02 | 343.04% |
The current PE Ratio of Sinew Pharma Inc. (6634.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.20
5-year avg
-42.38
10-year avg
-37.42
Sinew Pharma Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinew Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sinew Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sinew Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Sinew Pharma Inc. (6634.TWO)?
What is the highest PE Ratio for Sinew Pharma Inc. (6634.TWO)?
What is the 3-year average PE Ratio for Sinew Pharma Inc. (6634.TWO)?
What is the 5-year average PE Ratio for Sinew Pharma Inc. (6634.TWO)?
How does the current PE Ratio for Sinew Pharma Inc. (6634.TWO) compare to its historical average?